Skip to main content
. 2022 Aug 11;20:100191. doi: 10.1016/j.ahjo.2022.100191

Table 1.

Heterogeneity test for timing of ASA administration (inpatient versus prophylaxis) showed no difference in mortality. Heterogeneity test for studies included and not included in prior meta-analyses showed no difference in mortality.

P-Value
Heterogeneity Test for timing (inpatient vs prophylactic)
Risk ratio 0.16
Hazard ratio 0.19



Heterogeneity test for previous inclusion (yes vs no)
Risk ratio 0.14
Hazard ratio 0.44